stockportfolio.pro
Stocks / CNC vs DXCM
CNC vs DXCM
Centene Corporation and DexCom, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
CNC is the larger company ($29.9B vs $27.5B). On the fundamentals, DXCM grows revenue faster (19.3% vs 11.9%); DXCM earns a higher net margin (17.9% vs -3.4%); DXCM has the stronger return on equity (30.5% vs -33.4%). Full numbers below — the stronger figure on each row is in green.
| Centene Corporation (CNC) | DexCom, Inc. (DXCM) | |
|---|---|---|
| Market cap | $29.9B | $27.5B |
| Revenue (latest FY) | $194.78B | $4.66B |
| Net income (latest FY) | $-6.67B | $836.30M |
| Revenue growth (5y CAGR) | 11.9% | 19.3% |
| Net margin | -3.4% | 17.9% |
| Return on equity | -33.4% | 30.5% |
| P/E ratio | — | 30.6 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 9 | 7 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full CNC vs DXCM breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CNC's full financials → Open DXCM's full financials →More comparisons
Frequently asked questions
Which is bigger, CNC or DXCM?
Centene Corporation is larger by market capitalization — $29.9B versus $27.5B.
Which grows faster, CNC or DXCM?
Over the last five fiscal years, DexCom, Inc. grew revenue faster — 19.3%/yr versus 11.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.